Why the study?
Does the combination of left ventricular systolic dysfunction and renal dysfunction increase 1-year mortality and MACE in patients after primary percutaneous coronary intervention?
Does the combination of left ventricular systolic dysfunction and renal dysfunction increase 1-year mortality and MACE in patients after primary percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Evaluating renal function in patients with LVSD after primary PCI enables precise risk stratification for long-term adverse events.
The LVSD-RD combination is associated with an approximately five-fold increase in 1-year overall mortality and MACE after pPCI. The evaluation of the renal function in patients with LVSD represents a simple method which enables a more precise stratification of the risks related to the occurrence of adverse events in long-term patient follow-up.
No takes yet. Share an insight, caveat, or question.
Savić et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: